[2-[3-bromo-5-[[4-chloro-2-methyl-6-(propan-2-ylcarbamoyl)phenyl]carbamoyl]pyrazol-1-yl]-3-pyridinyl]chloranium
C20H19BrCl2N5O2+ — CID 153030082
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-[3-bromo-5-[[4-chloro-2-methyl-6-(propan-2-ylcarbamoyl)phenyl]carbamoyl]pyrazol-1-yl]-3-pyridinyl]chloranium
[2-[3-bromo-5-[[4-chloro-2-methyl-6-(propan-2-ylcarbamoyl)phenyl]carbamoyl]pyrazol-1-yl]-3-pyridinyl]chloranium (PubChem CID 153030082) has the molecular formula C20H19BrCl2N5O2+ and a molecular weight of 512.22 g/mol. Its IUPAC name is [2-[3-bromo-5-[[4-chloro-2-methyl-6-(propan-2-ylcarbamoyl)phenyl]carbamoyl]pyrazol-1-yl]-3-pyridinyl]chloranium.
Molecular Properties
| Compound Name | [2-[3-bromo-5-[[4-chloro-2-methyl-6-(propan-2-ylcarbamoyl)phenyl]carbamoyl]pyrazol-1-yl]-3-pyridinyl]chloranium |
|---|---|
| PubChem CID | 153030082 |
| Molecular Formula | C20H19BrCl2N5O2+ |
| Molecular Weight | 512.22 g/mol |
| Exact Mass | 510.01 |
| IUPAC Name | [2-[3-bromo-5-[[4-chloro-2-methyl-6-(propan-2-ylcarbamoyl)phenyl]carbamoyl]pyrazol-1-yl]-3-pyridinyl]chloranium |
| SMILES | Cc1cc(Cl)cc(C(=O)NC(C)C)c1NC(=O)c1cc(Br)nn1-c1ncccc1[ClH+] |
| InChI | InChI=1S/C20H18BrCl2N5O2/c1-10(2)25-19(29)13-8-12(22)7-11(3)17(13)26-20(30)15-9-16(21)27-28(15)18-14(23)5-4-6-24-18/h4-10,23H,1-3H3,(H-,25,26,29,30)/p+1 |
| InChIKey | VDQIPFRLZGWAOH-UHFFFAOYSA-O |
| XLogP | 4.08 |
| TPSA | 88.91 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 512.22 |
| LogP ≤ 5 | 4.08 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153030082 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.